Villere St Denis J & CO LLC Ligand Pharmaceuticals Inc Transaction History

Villere St Denis J & CO LLC

  • $1.15 Billion
  • Q3 2024

A detailed history of Villere St Denis J & CO LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Villere St Denis J & CO LLC holds 474,858 shares of LGND stock, worth $53 Million. This represents 4.12% of its overall portfolio holdings.

Number of Shares
474,858
Previous 483,913 1.87%
Holding current value
$53 Million
Previous $40.8 Million 16.66%
% of portfolio
4.12%
Previous 3.66%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
SELL
$82.7 - $110.11 $748,848 - $997,046
-9,055 Reduced 1.87%
474,858 $47.6 Million
Q2 2024

Aug 06, 2024
SELL
$68.53 - $87.91 $468,676 - $601,216
-6,839 Reduced 1.39%
483,913 $40.8 Million
Q1 2024

Apr 25, 2024
BUY
$68.64 - $89.2 $4.3 Million - $5.59 Million
62,701 Added 14.65%
490,752 $35.9 Million
Q4 2023

Jan 25, 2024
SELL
$49.57 - $72.63 $501,152 - $734,289
-10,110 Reduced 2.31%
428,051 $30.6 Million
Q3 2023

Oct 20, 2023
SELL
$58.86 - $72.67 $2.43 Million - $3 Million
-41,286 Reduced 8.61%
438,161 $26.3 Million
Q2 2023

Jul 18, 2023
SELL
$69.53 - $79.33 $94,560 - $107,888
-1,360 Reduced 0.28%
479,447 $34.6 Million
Q1 2023

Apr 25, 2023
SELL
$65.67 - $77.08 $166,801 - $195,783
-2,540 Reduced 0.53%
480,807 $35.4 Million
Q4 2022

Jan 18, 2023
SELL
$61.72 - $96.74 $478,947 - $750,702
-7,760 Reduced 1.58%
483,347 $32.3 Million
Q3 2022

Oct 17, 2022
SELL
$0.01 - $107.56 $49 - $529,302
-4,921 Reduced 0.99%
491,107 $42.3 Million
Q2 2022

Jul 18, 2022
SELL
$74.52 - $117.06 $1.1 Million - $1.73 Million
-14,815 Reduced 2.9%
496,028 $44.3 Million
Q1 2022

Apr 19, 2022
SELL
$94.99 - $151.56 $773,693 - $1.23 Million
-8,145 Reduced 1.57%
510,843 $57.5 Million
Q4 2021

Jan 19, 2022
SELL
$127.69 - $165.85 $5.79 Million - $7.52 Million
-45,361 Reduced 8.04%
518,988 $80.2 Million
Q3 2021

Oct 19, 2021
SELL
$102.33 - $144.73 $3.07 Million - $4.35 Million
-30,031 Reduced 5.05%
564,349 $78.6 Million
Q2 2021

Jul 19, 2021
BUY
$113.03 - $155.64 $6.48 Million - $8.93 Million
57,352 Added 10.68%
594,380 $78 Million
Q1 2021

Apr 19, 2021
SELL
$99.52 - $215.83 $10.5 Million - $22.7 Million
-105,045 Reduced 16.36%
537,028 $81.9 Million
Q4 2020

Jan 26, 2021
SELL
$80.55 - $106.05 $1.72 Million - $2.26 Million
-21,310 Reduced 3.21%
642,073 $63.9 Million
Q3 2020

Oct 27, 2020
BUY
$89.56 - $126.72 $1.41 Million - $1.99 Million
15,715 Added 2.43%
663,383 $63.2 Million
Q2 2020

Jul 29, 2020
BUY
$68.28 - $123.65 $813,214 - $1.47 Million
11,910 Added 1.87%
647,668 $72.4 Million
Q1 2020

Apr 30, 2020
BUY
$63.37 - $107.88 $40.3 Million - $68.6 Million
635,758 New
635,758 $46.2 Million

Others Institutions Holding LGND

# of Institutions
257
Shares Held
18.2M
Call Options Held
26.8K
Put Options Held
9.3K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.88B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Villere St Denis J & CO LLC Portfolio

Follow Villere St Denis J & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Villere St Denis J & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Villere St Denis J & CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email